Indivior Pharmaceuticals, Inc. (INDV) Total liabilities 2023–2025
Indivior Pharmaceuticals, Inc. (INDV) total liabilities at each fiscal year-end, per SEC filings.
$1.3BFY2025 · since FY2023: $1.9B → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3B | -21.3% |
| FY2024 | $1.7B | -14.9% |
| FY2023 | $1.9B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Net marginINDV Gross profitINDV Gross marginINDV Operating incomeINDV Operating marginINDV Operating cash flowINDV Free cash flowINDV Capital expendituresINDV Return on equityINDV Stock buybacksINDV Dividends paidINDV Total assetsINDV Shareholders’ equityINDV overview →